Reversible covalent direct thrombin inhibitors

INTRODUCTION: In recent years, the traditional treatments for thrombotic diseases, heparin and warfarin, are increasingly being replaced by novel oral anticoagulants offering convenient dosing regimens, more predictable anticoagulant responses, and less frequent monitoring. However, these drugs can...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:PLoS One
Päätekijät: Sivaraja, Mohanram, Pozzi, Nicola, Rienzo, Matthew, Lin, Kenneth, Shiau, Timothy P., Clemens, Daniel M., Igoudin, Lev, Zalicki, Piotr, Chang, Stephanie S., Estiarte, M. Angels, Short, Kevin M., Williams, David C., Datta, Anirban, Di Cera, Enrico, Kita, David B.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Public Library of Science 2018
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6072017/
https://ncbi.nlm.nih.gov/pubmed/30071045
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0201377
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia